Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 581363, 10 pages
http://dx.doi.org/10.1155/2012/581363
Review Article

Lipoplatin Formulation Review Article

1First Oncology Clinic, Errikos Dunant Hospital, Athens, Greece
2Regulon Inc. and Regulon AE, Afxentiou 7, Alimos, 17455 Athens, Greece

Received 29 May 2011; Accepted 24 June 2011

Academic Editor: Rassoul Dinarvand

Copyright © 2012 G. P. Stathopoulos and T. Boulikas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [80 citations]

The following is the list of published articles that have cited the current article.

  • Nial J Wheate, “Nanoparticles: the future for platinum drugs or a research red herring?,” Nanomedicine, vol. 7, no. 9, pp. 1285–1287, 2012. View at Publisher · View at Google Scholar
  • Anne-Laure Lainé, and Catherine Passirani, “Novel metal-based anticancer drugs: a new challenge in drug delivery,” Current Opinion in Pharmacology, vol. 12, no. 4, pp. 420–426, 2012. View at Publisher · View at Google Scholar
  • Susana Patricia Egusquiaguirre, Manuela Igartua, Rosa Maria Hernandez, and Jose Luis Pedraz, “Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research,” Clinical & Translational Oncology, vol. 14, no. 2, pp. 83–93, 2012. View at Publisher · View at Google Scholar
  • Tianyao Huo, Rolf F. Barth, Weilian Yang, Robin J. Nakkula, Rumiana Koynova, Boris Tenchov, Abhik Ray Chaudhury, Lawrence Agius, Teni Boulikas, Helene Elleaume, and Robert J. Lee, “Preparation, Biodistribution and Neurotoxicity of Liposomal Cisplatin following Convection Enhanced Delivery in Normal and F98 Glioma Bearing Rats,” Plos One, vol. 7, no. 11, 2012. View at Publisher · View at Google Scholar
  • Hsin-I Chang, and Ming-Kung Yeh, “Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy,” International Journal Of Nanomedicine, vol. 7, pp. 49–60, 2012. View at Publisher · View at Google Scholar
  • Pranali P Deshpande, Swati Biswas, and Vladimir P Torchilin, “Current trends in the use of liposomes for tumor targeting,” Nanomedicine, vol. 8, no. 9, pp. 1509–1528, 2013. View at Publisher · View at Google Scholar
  • Naike Casagrande, Monica De Paoli, Marta Celegato, Cinzia Borghese, Maurizio Mongiat, Alfonso Colombatti, and Donatella Aldinucci, “Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer,” Gynecologic Oncology, 2013. View at Publisher · View at Google Scholar
  • Yuchen Fan, and Qiang Zhang, “Development of liposomal formulations: From concept to clinical investigations,” Asian Journal of Pharmaceutical Sciences, 2013. View at Publisher · View at Google Scholar
  • Ichiro Kawada, Rifat Hasina, Frances E Lennon, Vytautas P Bindokas, Peter Usatyuk, Yi-Hung C Tan, Soundararajan Krishnaswamy, Qudsia Arif, George Carey, Robyn D Hseu, Matthew Robinson, Maria Tretiakova, Toni M Brand, Mari Iida, Mark K Ferguson, Deric L Wheeler, Aliya N Husain, Viswanathan Natarajan, Everett E Vokes, Patrick A Singleton, and Ravi Salgia, “Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: Relevance to lung cancer,” Cancer Biology & Therapy, vol. 14, no. 7, pp. 679–691, 2013. View at Publisher · View at Google Scholar
  • Shayne Cox Gad, Gaurav Bajaj, and Yoon YeoPharmaceutical Sciences Encyclopedia, 2013. View at Publisher · View at Google Scholar
  • Sara Zalba, and Maria J. Garrido, “Liposomes, a promising strategy for clinical application of platinum derivatives,” Expert Opinion On Drug Delivery, vol. 10, no. 6, pp. 829–844, 2013. View at Publisher · View at Google Scholar
  • Catherine A Schütz, Lucienne Juillerat-Jeanneret, Heinz Mueller, Iseult Lynch, and Michael Riediker, “Therapeutic nanoparticles in clinics and under clinical evaluation,” Nanomedicine, vol. 8, no. 3, pp. 449–467, 2013. View at Publisher · View at Google Scholar
  • Heveline Silva, Ana Candida A. Silva, Fernanda O. Lemos, Rubens L. Monte-Neto, Ana Paula S. Fontes, Miriam T.P. Lopes, and Frédéric Frézard, “Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes,” Anti-Cancer Drugs, vol. 24, no. 2, pp. 131–139, 2013. View at Publisher · View at Google Scholar
  • xue xue, Matthew D. Hall, Qiang Zhang, Paul C Wang, Michael M. Gottesman, and Xing-Jie Liang, “Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking,” ACS Nano, pp. 131112134654008, 2013. View at Publisher · View at Google Scholar
  • Gopalakrishna Pillai, and Maria L Ceballos-Coronel, “Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists,” SAGE Open Medicine, vol. 1, pp. 205031211351375, 2013. View at Publisher · View at Google Scholar
  • Hardeep S. Oberoi, Natalia V. Nukolova, Alexander V. Kabanov, and Tatiana K. Bronich, “Nanocarriers for delivery of platinum anticancer drugs,” Advanced Drug Delivery Reviews, 2013. View at Publisher · View at Google Scholar
  • Antonella Accardo, Gaetano Mangiapia, Luigi Paduano, Giancarlo Morelli, and Diego Tesauro, “Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery,” Journal of Peptide Science, vol. 19, no. 4, pp. 190–197, 2013. View at Publisher · View at Google Scholar
  • Leticia Hosta-Rigau, Yan Zhang, Boon M. Teo, Almar Postma, and Brigitte Staedler, “Cholesterol - a biological compound as a building block in bionanotechnology,” Nanoscale, vol. 5, no. 1, pp. 89–109, 2013. View at Publisher · View at Google Scholar
  • Yi Shi, Jerry Goodisman, and James C. Dabrowiak, “Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin,” Inorganic Chemistry, vol. 52, no. 16, pp. 9418–9426, 2013. View at Publisher · View at Google Scholar
  • Demin Liu, Chunbai He, Andrew Z. Wang, and Wenbin Lin, “Application of liposomal technologies for delivery of platinum analogs in oncology,” International Journal Of Nanomedicine, vol. 8, pp. 3309–3319, 2013. View at Publisher · View at Google Scholar
  • Michael G. Apps, Alaina J. Ammit, Alice Gu, and Nial J. Wheate, “Analysis of montmorillonite clay as a vehicle in platinum anticancer drug delivery,” Inorganica Chimica Acta, vol. 421, pp. 513–518, 2014. View at Publisher · View at Google Scholar
  • Chun-Nam Lok, Taotao Zou, Jing-Jing Zhang, Iris Wing-Shan Lin, and Chi-Ming Che, “Controlled-Release Systems for Metal-Based Nanomedicine: Encapsulated/Self-Assembled Nanoparticles of Anticancer Gold(III)/Platinum(II) Complexes and Antimicrobial Silver Nanoparticles,” Advanced Materials, vol. 26, no. 31, pp. 5550–5557, 2014. View at Publisher · View at Google Scholar
  • Rabbab Oun, Jane A. Plumb, and Nial J. Wheate, “A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol,” Journal of Inorganic Biochemistry, vol. 134, pp. 100–105, 2014. View at Publisher · View at Google Scholar
  • Xiaoyi Sun, Jinliang Chen, Xiaohui Gu, Wenquan Liang, and Junbo Wang, “Efficacy and toxicity of cisplatin liposomes modified with polyethylenimine,” Pharmazie, vol. 69, no. 4, pp. 281–286, 2014. View at Publisher · View at Google Scholar
  • Ece Bayir, Eyup Bilgi, and Aylin Sendemir Urkmez, “Implementation of Nanoparticles in Cancer Therapy,” Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials, pp. 447–491, 2014. View at Publisher · View at Google Scholar
  • Georg Pabst, Norbert Kuƒçerka, Mu-Ping Nieh, John Katsaras, Aleksandr Piroyan, Alexander Koshkaryev, Robert Riehle, and Vladimir Torchilin, “Polymer-Modified Liposomes,” Liposomes, Lipid Bilayers and Model Membranes, pp. 317–340, 2014. View at Publisher · View at Google Scholar
  • Naike Casagrande, Marta Celegato, Cinzia Borghese, Maurizio Mongiat, Alfonso Colombatti, and Donatella Aldinucci, “Preclinical Activity of the Liposomal Cisplatin Lipoplatin in Ovarian Cancer,” Clinical Cancer Research, vol. 20, no. 21, pp. 5496–5506, 2014. View at Publisher · View at Google Scholar
  • Vladimir P. Torchilin, “Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery,” Nature Reviews Drug Discovery, 2014. View at Publisher · View at Google Scholar
  • Ilya G. Glezerman, “Drug Nephropathies,” Renal disease in cancer patients, pp. 195–208, 2014. View at Publisher · View at Google Scholar
  • Michael G. Apps, Eugene H. Y. Choi, and Nial J. Wheate, “The state-of-play and future of platinum drugs,” Endocrine-Related Cancer, vol. 22, no. 4, pp. R219–R233, 2015. View at Publisher · View at Google Scholar
  • Gino K. In, and Jorge Nieva, “Emerging chemotherapy agents in lung cancer: nanoparticle therapeutics for non-small cell lung cancer,” Translational Cancer Research, vol. 4, no. 4, pp. 340–355, 2015. View at Publisher · View at Google Scholar
  • Wen Zhang, Changzheng Li, Chengwu Shen, Yuguo Liu, Xiaoting Zhao, Ying Liu, Dongna Zou, Zhenfa Gao, and Chunwen Yue, “Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment,” Drug Delivery, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Edgar Pérez-Herrero, and Alberto Fernández-Medarde, “Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 93, pp. 52–79, 2015. View at Publisher · View at Google Scholar
  • Bhushan S. Pattni, Vladimir V. Chupin, and Vladimir P. Torchilin, “New Developments in Liposomal Drug Delivery,” Chemical Reviews, pp. 150526165100008, 2015. View at Publisher · View at Google Scholar
  • Philipp Schattling, Yan Zhang, Boon M. Teo, and Brigitte StädlerReviews in Cell Biology and Molecular Medicine, pp. 335–385, 2015. View at Publisher · View at Google Scholar
  • Srinivas Ganta, Amit Singh, Praveen Kulkarni, Amanda W. Keeler, Aleksandr Piroyan, Rupa R. Sawant, Niravkumar R. Patel, Barbara Davis, Craig Ferris, Sara O’Neal, William Zamboni, Mansoor M. Amiji, and Timothy P. Coleman, “EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy,” Pharmaceutical Research, 2015. View at Publisher · View at Google Scholar
  • Yang Li, and Li Yang, “Driving forces for drug loading in drug carriers,” Journal of Microencapsulation, pp. 1–18, 2015. View at Publisher · View at Google Scholar
  • P. Chellan, and P. J. Sadler, “The elements of life and medicines,” Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, vol. 373, no. 2037, pp. 20140182–20140182, 2015. View at Publisher · View at Google Scholar
  • Madhura Deshpande, and Vladimir P. Torchilin, “Liposomal Membrane Modification, Polymers for,” Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, pp. 4348–4368, 2015. View at Publisher · View at Google Scholar
  • Christopher G. England, Chin F. Ng, Victor van Berkel, and Hermann B. Frieboes, “A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity,” Current Drug Targets, vol. 16, no. 10, pp. 1057–1087, 2015. View at Publisher · View at Google Scholar
  • Annabelle Fülöp, Denis A. Sammour, Katrin Erich, Johanna von Gerichten, Peter van Hoogevest, Roger Sandhoff, and Carsten Hopf, “Molecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry,” Scientific Reports, vol. 6, pp. 33791, 2016. View at Publisher · View at Google Scholar
  • Donya Poy, Azim Akbarzadeh, Hasan Ebrahimi Shahmabadi, Meysam Ebrahimifar, Ali Farhangi, Maryam Farahnak Zarabi, Azam Akbari, Zahra Saffari, and Fatemeh Siami, “ Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study ,” Chemical Biology & Drug Design, 2016. View at Publisher · View at Google Scholar
  • Sara Jung, Zoltan Nagy, Martin Fassnacht, Gerard Zambetti, Max Weiss, Martin Reincke, Peter Igaz, Felix Beuschlein, and Constanze Hantel, “Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma,” Endocrine-Related Cancer, vol. 23, no. 10, pp. 825–837, 2016. View at Publisher · View at Google Scholar
  • Sally Stras, Timothy Holleran, Alaina Howe, and Stavroula Sofou, “Interstitial Release of Cisplatin from Triggerable Liposomes Enhances Efficacy against Triple Negative Breast Cancer Solid Tumor Analogues,” Molecular Pharmaceutics, 2016. View at Publisher · View at Google Scholar
  • Xin Sui, Chao Luo, Chong Wang, Fangwei Zhang, Jingyan Zhang, and Shouwu Guo, “Graphene quantum dots enhance anticancer activity of cisplatin via increasing its cellular and nuclear uptake,” Nanomedicine: Nanotechnology, Biology and Medicine, 2016. View at Publisher · View at Google Scholar
  • Qinqin Cheng, and Yangzhong Liu, “Multifunctional platinum-based nanoparticles for biomedical applications,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2016. View at Publisher · View at Google Scholar
  • Minghan Shi, David Fortin, Benoit Paquette, and Léon Sanche, “Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model,” Investigational New Drugs, 2016. View at Publisher · View at Google Scholar
  • Xiaopin Duan, Chunbai He, Stephen J. Kron, and Wenbin Lin, “Nanoparticle formulations of cisplatin for cancer therapy,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 8, no. 5, pp. 776–791, 2016. View at Publisher · View at Google Scholar
  • Timothy C. Johnstone, Kogularamanan Suntharalingam, and Stephen J. Lippard, “The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Paola Ringhieri, Alessandra Pannunzio, Angelina Boccarelli, Giancarlo Morelli, Mauro Coluccia, and Diego Tesauro, “Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells,” Journal of Liposome Research, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • Sophie C. Hofferberth, Mark W. Grinstaff, and Yolonda L. Colson, “Nanotechnology applications in thoracic surgery,” European Journal of Cardio-Thoracic Surgery, pp. ezw002, 2016. View at Publisher · View at Google Scholar
  • Marzia Marciello, Juan Pellico, Irene Fernandez-Barahona, Fernando Herranz, Jesus Ruiz-Cabello, and Marco Filice, “Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy,” Interface Focus, vol. 6, no. 6, pp. 20160055, 2016. View at Publisher · View at Google Scholar
  • Kaitlin A. Doucette, Kelly N. Hassell, and Debbie C. Crans, “Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs,” Journal of Inorganic Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Elham Ajorlou, and Ahmad Yari Khosroushahi, “Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors,” Cancer Chemotherapy and Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Virginia J. Yao, Sara D’Angelo, Kimberly S. Butler, Christophe Theron, Tracey L. Smith, Serena Marchiò, Juri G. Gelovani, Richard L. Sidman, Andrey S. Dobroff, C. Jeffrey Brinker, Andrew R.M. Bradbury, Wadih Arap, and Renata Pasqualini, “Ligand-targeted theranostic nanomedicines against cancer,” Journal of Controlled Release, 2016. View at Publisher · View at Google Scholar
  • S.P. Egusquiaguirre, J.L. Pedraz, R.M. Hernández, and M. Igartua, “Nanotherapeutic Platforms for Cancer Treatment: From Preclinical Development to Clinical Application,” Nanoarchitectonics for Smart Delivery and Drug Targeting, pp. 813–869, 2016. View at Publisher · View at Google Scholar
  • James P. Parker, Ziga Ude, and Celine J. Marmion, “Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer,” Metallomics, vol. 8, no. 1, pp. 43–60, 2016. View at Publisher · View at Google Scholar
  • Martina H. Stenzel, Aydan Dag, Manuela Callari, and Hongxu Lu, “Modulating the cellular uptake of platinum drugs with glycopolymers,” Polymer Chemistry, vol. 7, no. 5, pp. 1031–1036, 2016. View at Publisher · View at Google Scholar
  • Dunja Sobot, Simona Mura, and Patrick Couvreur, “How can nanomedicines overcome cellular-based anticancer drug resistance?,” J. Mater. Chem. B, 2016. View at Publisher · View at Google Scholar
  • Liangliang Dai, Junjie Liu, Zhong Luo, Menghuan Li, and Kaiyong Cai, “Tumor therapy: targeted drug delivery systems,” J. Mater. Chem. B, 2016. View at Publisher · View at Google Scholar
  • Zhou Hang, Matthew A Cooper, and Zyta M Ziora, “Platinum-based anticancer drugs encapsulated liposome and polymeric micelle formulation in clinical trials,” Biochemical Compounds, vol. 4, no. 1, pp. 1, 2016. View at Publisher · View at Google Scholar
  • Sania Naz, Hira Shahzad, Attarad Ali, and Muhammad Zia, “Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment,” Artificial Cells, Nanomedicine, and Biotechnology, pp. 1–18, 2017. View at Publisher · View at Google Scholar
  • Zhen Li, Shirui Tan, Shuan Li, Qiang Shen, and Kunhua Wang, “Cancer drug delivery in the nano era: An overview and perspectives,” Oncology Reports, vol. 38, no. 2, pp. 611–624, 2017. View at Publisher · View at Google Scholar
  • James C. Dabrowiak, “Platinum Drugs for Treating Cancer,” Metals in Medicine, pp. 91–156, 2017. View at Publisher · View at Google Scholar
  • Yuki Mochida, Horacio Cabral, and Kazunori Kataoka, “Polymeric micelles for targeted tumor therapy of platinum anticancer drugs,” Expert Opinion on Drug Delivery, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  • Costica Caizer, Alice Sandra Buteica, and Ion Mindrila, “Biocompatible Magnetic Oxide Nanoparticles with Metal Ions Coated with Organic Shell as Potential Therapeutic Agents in Cancer,” Metal Nanoparticles in Pharma, pp. 219–256, 2017. View at Publisher · View at Google Scholar
  • Katja Ursic, Spela Kos, Urska Kamensek, Maja Cemazar, Janez Scancar, Simon Bucek, Simona Kranjc, Barbara Staresinic, and Gregor Sersa, “Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma,” Bioelectrochemistry, 2017. View at Publisher · View at Google Scholar
  • Niki Foroud, Mehdi Ardjmand, Amir Heidarinasab, and Azim Akbarzadeh, “Delivery of cisplatin by folic acid-targeted liposomal nanoparticles into liver cancer cell line,” International Journal of Polymeric Materials and Polymeric Biomaterials, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Bing Feng, Fangyuan Zhou, Wenchao Lu, Dangge Wang, Tingting Wang, Cheng Luo, Hao Wang, Yaping Li, and Haijun Yu, “Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer,” Biomater. Sci., 2017. View at Publisher · View at Google Scholar
  • Xiaoyang Zhang, Yarong Liu, Yu Jeong Kim, John Mac, Rachel Zhuang, and Pin Wang, “Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment,” RSC Adv., vol. 7, no. 32, pp. 19685–19693, 2017. View at Publisher · View at Google Scholar
  • Di Wu, Mengjie Si, Hui-Yi Xue, and Ho-Lun Wong, “Nanomedicine applications in the treatment of breast cancer: current state of the art.,” International journal of nanomedicine, vol. 12, pp. 5879–5892, 2017. View at Publisher · View at Google Scholar
  • Ece Bayir, Eyup Bilgi, and Aylin Sendemir Urkmez, “Implementation of Nanoparticles in Cancer Therapy,” Pharmaceutical Sciences: Breakthroughs in Research and Practice, pp. 1212–1257, 2017. View at Publisher · View at Google Scholar
  • Ian Lambert, and Belinda Sørensen, “Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs,” International Journal of Molecular Sciences, vol. 19, no. 8, pp. 2249, 2018. View at Publisher · View at Google Scholar
  • Arthur Cássio de Lima Luna, Greice Kelle Viegas Saraiva, Gilberto Orivaldo Chierice, Henrique Hesse, and Durvanei Augusto Maria, “Antiproliferative and proapoptotic effects of DODAC/synthetic phosphoethanolamine on hepatocellular carcinoma cells,” BMC Pharmacology and Toxicology, vol. 19, no. 1, 2018. View at Publisher · View at Google Scholar
  • Haihua Xiao, Lesan Yan, Elizabeth M. Dempsey, Wantong Song, Ruogu Qi, Wenliang Li, Yubin Huang, Xiabin Jing, Dongfang Zhou, Jianxun Ding, and Xuesi Chen, “Recent progress in polymer-based platinum drug delivery systems,” Progress in Polymer Science, 2018. View at Publisher · View at Google Scholar
  • Najlaa S. Al-Radadi, “Green synthesis of platinum nanoparticles using Saudi’s Dates extract and their usage on the cancer cell treatment,” Arabian Journal of Chemistry, 2018. View at Publisher · View at Google Scholar
  • Amit A. Vernekar, Gilles Berger, Anna E. Czapar, Frank A. Veliz, David I. Wang, Nicole F. Steinmetz, and Stephen J. Lippard, “Speciation of Phenanthriplatin and Its Analogs in the Core of Tobacco Mosaic Virus,” Journal of the American Chemical Society, 2018. View at Publisher · View at Google Scholar
  • M. Matbou Riahi, A. Sahebkar, K. Sadri, S. Nikoofal-Sahlabadi, and M.R. Jaafari, “Stable and sustained release liposomal formulations of celecoxib: in vitro and in vivo anti-tumor evaluation,” International Journal of Pharmaceutics, 2018. View at Publisher · View at Google Scholar
  • Roger Gilabert-Oriol, Lina Chernov, Rebecca J. Deyell, and Marcel B. Bally, “Developing liposomal nanomedicines for treatment of patients with neuroblastoma,” Lipid Nanocarriers for Drug Targeting, pp. 361–411, 2018. View at Publisher · View at Google Scholar
  • Deepti Sharma, Navneet Sharma, Mallika Pathak, Paban K. Agrawala, Mitra Basu, and Himanshu Ojha, “Nanotechnology-based drug delivery systems,” Drug Targeting and Stimuli Sensitive Drug Delivery Systems, pp. 39–79, 2018. View at Publisher · View at Google Scholar